Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
N125978-5mg | 5mg | In stock | $9.90 | |
N125978-10mg | 10mg | In stock | $16.90 | |
N125978-25mg | 25mg | In stock | $34.90 | |
N125978-50mg | 50mg | In stock | $57.90 | |
N125978-100mg | 100mg | In stock | $94.90 | |
N125978-250mg | 250mg | In stock | $121.90 | |
N125978-500mg | 500mg | In stock | $147.90 | |
N125978-1g | 1g | In stock | $266.90 |
Synonyms | 41332-24-5|NP118809|1-[4-(Diphenylmethyl)-1-piperazinyl]-3,3-diphenyl-1-propanone|NP-118809|Z-160|1-(4-benzhydrylpiperazin-1-yl)-3,3-diphenylpropan-1-one|Z160|Piperazine, 1-(diphenylmethyl)-4-(1-oxo-3,3-diphenylpropyl)-|MK-6721|TX3R141LEP|NMED-160|39-1B4| |
---|---|
Specifications & Purity | Moligand™, ≥98% |
Biochemical and Physiological Mechanisms | In Vitro:NP118809 is a potent N-type calcium channel blocker, with an IC50 of 0.11 μM; also inhibits L-type calcium channel with an IC50 of 12.2 μM. NP118809 inhibits the hERG potassium channel in HEK cells, with an IC50 of 7.4 μM. In Vivo:NP118809 (25 mg |
Storage Temp | Store at -20°C |
Shipped In | Ice chest + Ice pads |
Grade | Moligand™ |
Action Type | BLOCKER, GATING INHIBITOR |
Mechanism of action | Voltage-gated N-type calcium channel alpha-1B subunit blocker |
ALogP | 6.1 |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
IUPAC Name | 1-(4-benzhydrylpiperazin-1-yl)-3,3-diphenylpropan-1-one |
---|---|
INCHI | InChI=1S/C32H32N2O/c35-31(25-30(26-13-5-1-6-14-26)27-15-7-2-8-16-27)33-21-23-34(24-22-33)32(28-17-9-3-10-18-28)29-19-11-4-12-20-29/h1-20,30,32H,21-25H2 |
InChi Key | VCPMZDWBEWTGNW-UHFFFAOYSA-N |
Canonical SMILES | C1CN(CCN1C(C2=CC=CC=C2)C3=CC=CC=C3)C(=O)CC(C4=CC=CC=C4)C5=CC=CC=C5 |
Isomeric SMILES | C1CN(CCN1C(C2=CC=CC=C2)C3=CC=CC=C3)C(=O)CC(C4=CC=CC=C4)C5=CC=CC=C5 |
PubChem CID | 4988454 |
Molecular Weight | 460.61 |
PubChem CID | 4988454 |
---|---|
CAS Registry No. | 41332-24-5 |
ChEMBL Ligand | CHEMBL604710 |
Enter Lot Number to search for COA:
To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
B2208157 | Certificate of Analysis | Nov 14, 2023 | N125978 |
B2208182 | Certificate of Analysis | Nov 14, 2023 | N125978 |
B2208193 | Certificate of Analysis | Nov 14, 2023 | N125978 |
B2208207 | Certificate of Analysis | Nov 14, 2023 | N125978 |
B2208216 | Certificate of Analysis | Nov 14, 2023 | N125978 |
B2208404 | Certificate of Analysis | Nov 14, 2023 | N125978 |
B2208406 | Certificate of Analysis | Nov 14, 2023 | N125978 |
B2208407 | Certificate of Analysis | Nov 14, 2023 | N125978 |
Solubility | insoluble in H2O; insoluble in EtOH; ≥63.4 mg/mL in DMSO |
---|